Skip to content
10-Q

Quarterly Report

LA JOLLA PHARMACEUTICAL CO

0001564590-21-054269

← back to feed
Filed
Nov 4, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Oct 22, 2021 27.52M sh
Shares Diluted Q3 2021 · Sep 30, 2021 27.5M sh
Shares Diluted Q3 2021 · Sep 30, 2021 34.21M sh
Shares Diluted Q3 2021 · Sep 30, 2020 27.37M sh
Shares Diluted Q3 2021 · Sep 30, 2020 27.31M sh
Capex Q3 2021 · Sep 30, 2021 $9K
Operating Cash Flow Q3 2021 · Sep 30, 2021 $25.08M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$30.36M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $46.77M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $21.22M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $27.76M
Stockholders Equity Q3 2021 · Sep 30, 2021 −$68.41M
Stockholders Equity Q3 2021 · Jun 30, 2021 −$67.44M
Stockholders Equity Q3 2021 · Mar 31, 2021 −$72.32M
Stockholders Equity Q3 2021 · Dec 31, 2020 −$88.09M
Stockholders Equity Q3 2021 · Sep 30, 2020 −$85.52M
Stockholders Equity Q3 2021 · Jun 30, 2020 −$75.21M
Stockholders Equity Q3 2021 · Mar 31, 2020 −$61.67M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$55.99M
Current Liabilities Q3 2021 · Sep 30, 2021 $16M
Current Liabilities Q3 2021 · Dec 31, 2020 $12.34M
Total Liabilities Q3 2021 · Sep 30, 2021 $168.7M
Total Liabilities Q3 2021 · Dec 31, 2020 $160.33M
Current Assets Q3 2021 · Sep 30, 2021 $65.92M
Current Assets Q3 2021 · Dec 31, 2020 $36.46M
Total Assets Q3 2021 · Sep 30, 2021 $100.29M
Total Assets Q3 2021 · Dec 31, 2020 $72.24M
Eps Diluted Q3 2021 · Sep 30, 2021 −$0.08
Eps Diluted Q3 2021 · Sep 30, 2021 $0.46
Eps Diluted Q3 2021 · Sep 30, 2020 −$0.43
Eps Diluted Q3 2021 · Sep 30, 2020 −$1.32
Eps Basic Q3 2021 · Sep 30, 2021 −$0.08
Eps Basic Q3 2021 · Sep 30, 2021 $0.58
Eps Basic Q3 2021 · Sep 30, 2020 −$0.43
Eps Basic Q3 2021 · Sep 30, 2020 −$1.32
Sga Expense Q3 2021 · Sep 30, 2021 $8.63M
Sga Expense Q3 2021 · Sep 30, 2021 $26.38M
Sga Expense Q3 2021 · Sep 30, 2020 $12.49M
Sga Expense Q3 2021 · Sep 30, 2020 $29.32M
Rd Expense Q3 2021 · Sep 30, 2021 $1.29M
Rd Expense Q3 2021 · Sep 30, 2021 $3.96M
Rd Expense Q3 2021 · Sep 30, 2020 $3.62M
Rd Expense Q3 2021 · Sep 30, 2020 $21.58M
Net Income Q3 2021 · Sep 30, 2021 −$2.26M
Net Income Q3 2021 · Sep 30, 2021 $15.89M
Net Income Q3 2021 · Jun 30, 2021 $3.73M
Net Income Q3 2021 · Mar 31, 2021 $14.42M
Net Income Q3 2021 · Sep 30, 2020 −$11.76M
Net Income Q3 2021 · Sep 30, 2020 −$35.94M
Net Income Q3 2021 · Jun 30, 2020 −$15.59M
Net Income Q3 2021 · Mar 31, 2020 −$8.59M
Operating Income Q3 2021 · Sep 30, 2021 $525K
Operating Income Q3 2021 · Sep 30, 2021 $21.81M
Operating Income Q3 2021 · Sep 30, 2020 −$9.53M
Operating Income Q3 2021 · Sep 30, 2020 −$32.45M
Revenue Q3 2021 · Sep 30, 2021 $13.31M
Revenue Q3 2021 · Sep 30, 2021 $63.51M
Revenue Q3 2021 · Sep 30, 2020 $9.07M
Revenue Q3 2021 · Sep 30, 2020 $22.47M